Symbiotec Pharmalab Ltd Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Symbiotec Pharmalab

Based on:

DeciZen not available for IPO

10 Year X-Ray of Symbiotec Pharmalab:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 16.2%13.4%14.7%15.1%14.5%16.9%29.1%11.9%0%15.8%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 389419438410528531623634564674528
Sales YoY Gr.-7.6%4.6%-6.4%28.9%0.7%17.3%1.8%-11.1%19.5%-
Adj EPS 65.38.57.98.913.324.511.34.415.60
YoY Gr.--11.6%60.7%-6.2%12.6%48.8%84.4%-54%-61.4%258.3%-
BVPS (₹) 455061.168.977.891115.8127.1123.1139.20
Adj Net
Profit
32.328.645.943.148.872.713461.723.985.4NAN
Cash Flow from Ops. 28.519.252.348.343.710915823.593.4147-
Debt/CF from Ops. 6.510.33.33.23.51.10.32.71.20.4-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 6.3%5%2.7%19.5%
Adj EPS 11.3%11.8%-13.9%258.3%
BVPS13.4%12.4%6.3%13.1%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
14.111.115.212.212.215.723.79.33.511.90
Op. Profit
Mgn %
1717.719.422.518.922.532.516.614.721.3NAN
Net Profit
Mgn %
8.36.810.510.59.313.721.59.74.212.7NAN
Debt to
Equity
0.80.70.50.40.40.20.10.10.20.1-
Working Cap
Days
1631982162462312602212463163260
Cash Conv.
Cycle
56841001351271361011371791120

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Symbiotec Pharmalab Ltd.

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 528 -
BVPS (₹.) 0 -
Reserves (₹ Cr.) 414 -
P/BV 0.00 -
PE 0.00 -
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 0
Face Value (₹) -
Industry PE 40.4

Management X-Ray of Symbiotec Pharmalab:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Symbiotec Pharmalab - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Symbiotec Pharmalab

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales389.06418.52437.66409.61527.77531.19622.86633.85563.59673.61
Operating Expenses 327.80346.25354.36318.97432.04411.80420.50528.55483.49530.67
Manufacturing Costs14.2024.0147.3337.0343.5145.2057.3755.5961.5769
Material Costs253.10249.25230.49202.32303.37257.03266.09354.23289.79321.57
Employee Cost 28.8042.0543.5849.3454.2564.4772.7781.7492.55101.60
Other Costs 31.7130.9432.9730.2930.9045.1124.2636.9939.5838.50
Operating Profit 61.2772.2783.3090.6495.73119.39202.37105.3080.09142.94
Operating Profit Margin (%) 15.7%17.3%19.0%22.1%18.1%22.5%32.5%16.6%14.2%21.2%
Other Income 9.843.136.717.594.863.179.015.6512.3719.76
Interest 15.0224.0418.9517.5917.8310.616.523.078.057.54
Depreciation 10.8015.3718.5020.1620.1221.1622.1825.1127.6237.26
Exceptional Items 00000000-64.570
Profit Before Tax 45.2935.9952.5660.4862.6490.79182.6782.77-7.78117.90
Tax 14.928.753.8618.4916.5418.2747.1121.0414.8828.95
Profit After Tax 30.3727.2448.7041.9946.1072.52135.5661.73-22.6688.95
PAT Margin (%) 7.8%6.5%11.1%10.3%8.7%13.7%21.8%9.7%-4.0%13.2%
Adjusted EPS (₹)5.65.09.07.78.413.324.811.3-4.116.3
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 244.27271.51332.22374.25425.23497.83633.35695.18672.81761.14
Share Capital 10.8710.8710.8710.8710.9410.9410.9410.9410.9410.94
Reserves 233.40260.64321.35363.38414.29486.90622.42684.25661.88750.20
Minority Interest0000000000
Debt171.50182.02153.84132.92144.26117.5046.4163.25106.6751.25
Long Term Debt47.0438.0830.1912.625.682.471.460.731.411.12
Short Term Debt124.46143.94123.64120.30138.58115.0344.9562.52105.2650.13
Trade Payables70.6090.3580.1364.47124.83108.02109.8284.8886.61226.92
Others Liabilities 42.2953.6150.3355.8447.4946.2152.2851.1749.0347.88
Total Liabilities 528.65597.50616.51627.47741.80769.55841.87894.48915.121,087.19

Fixed Assets

Gross Block217.28270.95257.82265.60281.60309.01348.53391.57418.23513.66
Accumulated Depreciation31.0546.1318.4238.5958.7179.40100.94125.49152.59189.84
Net Fixed Assets 186.23224.82239.40227.01222.89229.62247.58266.09265.65323.82
CWIP 30.552.831.176.7312.9730.5026.7322.6273.9019.36
Investments 102.4299.68103.31105.56111.33110.39122.59130.1765.6042.25
Inventories87.37126.07128.25127.94216.10230.85225.26245.41241.72332.61
Trade Receivables75.2799.41110.31122.78127.67106.92118.68143.66112.31125.43
Cash Equivalents 10.609.133.365.828.3228.5441.146.322.836.27
Others Assets 36.2235.5630.7231.6342.5232.7559.8980.22153.11237.45
Total Assets 528.65597.50616.51627.47741.80769.55841.87894.48915.121,087.19

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 28.4919.1752.2748.3243.74109157.7023.5193.35147.46
PBT 45.2935.9952.5660.4862.6490.79182.6782.77-7.78117.90
Adjustment 23.8634.5229.8031.1436.0133.7229.1322.9791.1525.36
Changes in Working Capital -30.88-46.38-17.37-27.91-40.228.68-11.57-58.8925.839.29
Tax Paid -9.79-4.96-12.72-17.30-13.25-24.19-42.53-23.34-15.82-35.09
Cash Flow From Investing Activity -88.39-37.49-7.62-15.61-26.97-69.91-78.99-33.94-132.50-80.80
Capex -84.98-29.30-35.18-16-23.70-48.42-41.51-41.58-71.75-40.12
Net Investments 0039.9426.7117.6030.222.840.44029.07
Others -3.40-8.19-12.38-26.32-20.87-51.72-40.327.20-60.76-69.76
Cash Flow From Financing Activity 70.13-6.93-44.34-31.70-14.19-42.23-79.0414.8436.53-62.98
Net Proceeds from Shares 0000500000
Net Proceeds from Borrowing 00-6.24000016.1700
Interest Paid -12.67-20.85-17.80-15.66-16.98-9.55-5.67-1.22-7.04-6.99
Dividend Paid 0000000000
Others 82.8113.92-20.30-16.04-2.21-32.68-73.38-0.1143.57-55.99
Net Cash Flow 10.24-25.250.3212.58-3.14-0.334.41-2.623.67

Finance Ratio

PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)13.2610.5616.1311.8911.5315.7123.979.29-3.3112.41
ROCE (%)16.213.3614.6915.1114.5216.9429.1211.930.0415.75
Asset Turnover Ratio0.850.750.740.660.770.70.80.740.620.67
PAT to CFO Conversion(x)0.940.71.071.150.951.51.160.38N/A1.66
Working Capital Days
Receivable Days617586104878164748364
Inventory Days7392104114119154130133158156
Payable Days98118135130114165149100108178

Symbiotec Pharmalab Ltd Stock News

Symbiotec Pharmalab Ltd FAQs

The current trading price of Symbiotec Pharmalab on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Symbiotec Pharmalab stood at ₹0.00.
The latest P/E ratio of Symbiotec Pharmalab as of 31-Dec-1969 is 0.00.
The latest P/B ratio of Symbiotec Pharmalab as of 31-Dec-1969 is 0.00.
The 52-week high of Symbiotec Pharmalab is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Symbiotec Pharmalab is ₹527.8 ( Cr.) .

About Symbiotec Pharmalab Ltd

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×